Will Microsoft Surface Rekindle RYOD?

The Microsoft Surface, whenever it arrives, is actually two machines. The lower end system running Windows RT seems destined to compete with the iPad within the general consumer market, while the higher end system running a full implementation of Windows 8 may indeed be perceived as a laptop computer rather than a tablet, and should be of interest to corporate buyers.

The Surface, if it works well, may compel may enterprise IT managers to try to rein in the current BYOD (Bring Your Own Device) movement that threatens chaos in the world. It seems eminently plausible for IT to embrace (if not extend) the Surface Windows 8 Pro model, and provide it as standard-issue equipment to company employees, in the old-fashioned RYOD (Receive Your Own Device) model.

The currently missing price point won’t be as much of an issue with the Pro model. I was issued a Thinkpad at an internal cost of $1,800 by a software company I worked for just a few years ago. A few people who complained enough got Macs, at much higher internal price points.

But the issue of whether the Surface will start with a pricing of $400 or $600 or $800 or more is less relevant to the higher end Pro.

Getting the Pro as a standard corporate provision will be splendidly ironic when it happens, because after all, Microsoft OS-based computers were the vanguard of the business PC revolution 30 years ago when corporate masses, tired of aloof mainframe IS managers, brought the new machines into their offices and integrated them into their everyday reality.

The IBM PC running Microsoft DOS were the original BYOD systems; now Microsoft stands as the bastion of the old guard. But no more speculation at this point – I’d like to see a real Surface machine work before I pronounce anything more about it.

read more

Apple, Motorola Both Denied Injunctions

Circuit Court Judge Richard Posner, arguably the most brilliant mind on the American bench, threw out the Android infringement litigation between Apple and Motorola Mobility late Friday with prejudice, denying Apple its hoped-for injunction against the Google satellite and its smartphones.

That goes for Motorola too.

“Neither party is entitled to an injunction,” Posner said. “Neither has shown that damages would not be an adequate remedy” to an injunction – (which is usually reserved for cases of imminent irreversible harm) – but both sides “failed to make a responsible calculation” of damages.

“They had an adequate legal remedy,” he said, “but failed to make a prima facie case of how much money, by way of such remedy, they are entitled to. That was a simple failure of proof.”

Apple has the stronger case but “By failing to present a minimally adequate damages case, Apple has disabled itself from arguing that damages would not provide a complete remedy, going forward in the form of running royalties, as well as backward.”

With prejudice means the cross-litigation can’t be re-filed, giving Apple, which claims Motorola copied its technology, a powerful thumping.

There is of course always the probability of appeal or they could go venue shopping. Otherwise, Judge Posner, whose patience was tried more than a little by the case, blasted the strategy of using patents to bar a rival from the market in his 38-page decision.

After tossing nearly all of Motorola’s patent claims against Apple and leaving Apple with more, the judge cancelled a jury trial that was supposed to start on June 11 on their two-year-old cross-complaints and heard arguments last Wednesday on the possibility of injunctions determined to decide the issue himself.

He found that Apple had dicey grounds for a ban in the light of possible workarounds and said enjoining Motorola’s phones would be “catastrophic” for the company.

It didn’t have a tight enough case. “Apple wanted me to allow into evidence,” the judge said, “media reports attesting to what a terrific product the iPhone is. I said I would not permit this because the quality of the iPhone (and of related Apple products, primarily the iPad) and consumers’ regard for it have, so far as the record shows, nothing to do with the handful of patent claims that I had ruled presented triable issues of infringement. Apple’s ‘feel good’ theory does not indicate that infringement of these claims (if they were infringed) reduced Apple’s sales or market share, or impaired consumer goodwill toward Apple products.”

There’s “danger,” he said, “that Apple’s goal in obtaining an injunction is harassment of its bitter rival…The notion that these minor-seeming infringements have cost Apple market share and consumer goodwill is implausible, has virtually no support in the record, and so fails to indicate that the benefits to Apple from an injunction would exceed the costs to Motorola.”

“smallerAn injunction,” he said, “that imposes greater costs on the defendant than it confers benefits on the plaintiff reduces net social welfare.”

Meanwhile, Posner had left Motorola with one FRAND-pledged wireless patent to sue on after weeding out the others.

He said Motorola’s FRAND pledges barred it from seeking an injunction and that Motorola offered “no reasonable evidence for calculating a reasonable royalty” in light of its gargantuan licensing demands for 2.25% of Apple’s device sales.

“I don’t see how,” he wrote, “given FRAND, I would be justified in enjoining Apple from infringing the ‘898 unless Apple refuses to pay a royalty that meets the FRAND requirement. By committing to license its patents on FRAND terms, Motorola committed to license the ‘898 to anyone willing to pay a FRAND royalty and thus implicitly acknowledged that a royalty is adequate compensation for a license to use that patent. How could it do otherwise? How could it be permitted to enjoin Apple from using an invention that it contends Apple must use if it wants to make a cell phone with UMTS telecommunications capability – without which it would not be a cell phone.”

Judge Posner also quashed Apple’s proposal to limit the injunction and force Motorola to remove Apple-patented features from its phones within three months of launch. He said it would be too hard and too costly to administer for both Motorola and the court, and forcing Motorola to sell inferior technology would serve no social good and create the unhappy prospect of Apple then filing more lawsuits claiming Motorola still infringed à la Apple and HTC.

He suggested Apple license the relevant patents to Motorola.

FOSS Patents says the only thing that’s going to stop the worldwide patent disputes that Judge Posner loathes is a global settlement and the only way to achieve a settlement is either through an injunction that endangers sales or draconian damages.

According to Gartner Android owns 47% of the market and iOS has 23%.

The Apple-Google relationship is expected to deteriorate further if Google puts out its own branded phone, as widely reported

read more

Just Published – Two New Best Practices Whitepapers About Parallels Plesk Panel 11

In anticipation of this week’s Parallels Plesk Panel 11 launch, two new best practices whitepapers have been published in the Marketing Best Practices section of Parallels PartnerNet.

 

The first white paper details how Parallels Plesk Panel 11 is the only Web hosting control panel with an integrated website design package, SaaS storefront, and billing system. By leveraging these and other key features of Parallels Plesk Panel, you can increase your average revenue per user (ARPU), reduce customer churn, reduce administrative costs, and minimize the cost of customer acquisition. This white paper outlines the key features of Parallels Plesk Panel—features that will help you maximize your profits and grow your business.

 

The second whitepaper dives a bit deeper into Parallels Plesk Panel 11 with Web Presence Builder. The Web Presence Builder tool directly addresses two of the most important things that an SMB needs besides hosting itself – help with website design and social media integration. By following the best practices in this paper, you will be able not only to boost ARPU but also to enhance customer “stickiness.”

 

– Josh Beil
Director of Service Provider Marketing
@joshbeil

Enterprises Secure Cloud Infrastructure and Social Networking Investments

According to “The State of Adoption of Cloud Applications” a recent survey from Tata Consultancy Services (TCS) determined that overcoming the fear of security risks remains the key to adopting and benefiting from cloud applications. In addition it found that while companies globally admitted this is the biggest challenge to leveraging cloud today, those in the US and Europe remain especially conservative in their approach to cloud adoption for the fear of data security breaches.
Dome9 makes the cloud security stack manageable, securing cloud servers and making them virtually invisible to hackers. Using a patent-pending policy automation and security centralization, Dome9 makes it easy to create a simple and scalable front-line defense to secure any server in any cloud. And they have incorporated into the company’s service new strong, two-factor authentication.

read more

OpenNebula 3.6 Beta Cloud Management Toolkit Is Out

The OpenNebula project has just announced the availability of the beta release of OpenNebula 3.6 (Lagoon).
OpenNebula 3.6 features a new hotpluging mechanism for disk volumes that supports attaching either volatile volumes or existing images to a running VM. OpenNebula 3.6 brings new Quota and Accounting tools, so now they are included in the OpenNebula core to enhance their integration with the existing AuthZ & AuthN mechanisms and other related tools (e.g. Sunstone). There are some other new features like VM rescheduling, hard reboots, cloning of disk images…
OpenNebula 3.6 also features improvements in other systems, especially in Sunstone’s interface with the redesign of several tabs as well as in the OpenNebula Zones.

read more

MineralTree Raises $6.3 Million to Accelerate Growth

MineralTree, Inc., maker of the cloud-based, secure payments solution specifically designed for small and medium businesses (SMBs), has received $6.3 million of venture financing. Led by Fidelity Growth Partners India with full participation from initial investor, .406 Ventures, the funding will be used to further enhance the capabilities of the MineralTree platform and to accelerate its partnerships with banks and distribution to their SMB customers.
The MineralTree solution is a secure, cloud-based payment and cash management solution that meets the needs of companies with annual revenue of $500,000 to $50 million. Offered to SMBs as a private labeled solution by MineralTree’s bank partners, the system provides unmatched security, mobility and visibility into the management of B2B (business-to-business) payments, via a secure web browser or iPad application.

read more

Cloud Computing: Salesforce Buys ChoicePass to Shut It Down

Salesforce has bought SMB-focused corporate perks and employee rewards management start-up ChoicePass a year after the outfit drummed up $250,000 in seed money.
Its site will be shut down on June 30 and the team that put the operation together sucked up into Salesforce according to an official blog posting.
It said that “Since launching our Perks product, we’ve found that there is massive demand from businesses for innovative ways to manage employee engagement, rewards and incentives. It has been an amazing experience for us to work with such great companies, partners and of course, people.”
It got as far as fielding an Android app last month and was supposed to turn out an iPhone and iPad app next.

read more

Mainframes to Mobility

Much of the success of the Cloud delivery model is attributed to the implementation of similar concepts through mainframe computing several years back. The concepts of multi-tenancy, workload management, virtualization, and chargeback accounting all are basic tenants of the mainframe.
Over the years mainframes have reinvented themselves to continue to find a place in the enterprise landscape. Recent announcements from IBM on System Z, IBM zEnterprise 196 (z196), IBM zEnterprise 114 (z114) have laid a path for enterprises to adopt Private Clouds using mainframes. The zEnterprise family provides a system designed specifically to address IaaS on a private heterogeneous cloud where the components run on the same architecture, a single hardware or operating system platform. The private cloud can be hosted within the organization or through an external provider.

read more

Cloud Computing: Fujitsu to OEM Eucalyptus Cloud Platform

Fujitsu has cut an OEM deal with Eucalyptus Systems to deliver a private IaaS cloud solution.
Fujitsu Frontech North America Inc is going to use Eucalyptus’ open source private cloud platform to power its pre-packaged NuVola Private Cloud Platform, otherwise consisting of Fujitsu’s x86 Primergy servers, Eternus storage appliances and virtualization software.
Since Eucalyptus is compatible and integrated with Amazon’s public cloud, Fujitsu’s will be too, adding to Amazon’s luster as the de facto cloud standard.
Frontech customers are in manufacturing, retail, healthcare, government, education, financial services, the enterprise and communications.
The NuVola Private Cloud Platform is available immediately.

read more

Medidata Solutions to Show New Clinical Cloud Products, Enhancements at DIA

English: Medidata Solutions Logo

Medidata Solutions will showcase new products and features that broaden its clinical cloud platform at the upcoming Drug Information Association’s (DIA) Annual Meeting, June 24-28 in Philadelphia, Pa. Addressing new industry regulations, the need for broad safety reporting and improvements to site monitoring processes, these enhancements to Medidata’s comprehensive solutions will offer drug developers new capabilities for overcoming key research challenges.

“Sponsors are under more pressure than ever to cut costs, improve efficiency and adhere to increased regulations, requiring innovation and real-time operational analytics across the clinical research chain from concept to conclusion,” said Glen de Vries, president of Medidata Solutions. “We are continuously broadening our solution set to empower sponsors to improve their research clinical systems at every point in the clinical process, including trial planning, monitoring, site payments and safety.”

From booth #3101, Medidata will be providing demos of key products and new features to enable sponsors to achieve key goals, including:

  • Driving a New Monitoring Paradigm
    The company’s first
    solution for managing site quality and the latest addition to the
    Medidata Insights™ family of clinical business analytics offerings, Medidata
    Insights SQM™ combines advanced data visualization with seamless
    real-time data availability with the rest of Medidata’s platform to
    deliver turnkey site quality management – further enabling the
    industry’s shift to simplified remote monitoring of site and data
    quality resulting from the 2011 FDA clarification on source document
    verification (SDV).
  • Automating Safety Processes with Electronic Adverse Event Transfer
    To
    help drug developers meet post-marketing expedited reporting
    obligations within the new European pharmacovigilance legislation, Medidata
    Rave Safety Gateway™ expanded its capabilities for sites to
    electronically transfer non-serious safety case data – in addition to
    serious safety case data – to sponsors’ safety systems, eliminating
    paper-based manual processes, reducing query cycles between sites and
    sponsors’ safety groups and minimizing reconciliation between safety
    and clinical databases.
  • Ensuring Timely Investigator Payments
    Due to the
    complexity of triggering investigator payments from sponsor-set
    milestones, site payments are often delayed. The out-of-the box
    integration of Medidata
    CTMS™ and Medidata
    Rave® electronic data capture (EDC) improves the
    efficiency of clinical operations, streamlining workflows in areas
    such as site monitoring and site payments. Now, Medidata Rave EDC data
    is pulled into Medidata CTMS™ monitor reports, increasing the accuracy
    of reporting and timeliness of payment triggers.
  • Assuring Market Value Compliance and Faster Budget Agreements
    Designed
    for sponsors receiving investigator-sponsored proposals from sites, Medidata
    Grants Manager Investigator Initiated™ offers drug developers
    clarity and uniformity in judging pricing and conduct of their
    submitted funding requests.
  • Ensuring the Right Randomization Approach to Meet Study GoalsMedidata
    Balance™ now provides the block randomization methodology in
    addition to dynamic allocation randomization, extending its use to new
    segments of the life science industry by permitting researchers to use
    the approach that best suits their study goals.


The cloud news categorized.